Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative NBIX - Neurocrine Biosciences, Inc.
1.01 B
LAST VALUE
15.68%
2 YEAR CAGR
23.25%
5 YEAR CAGR
49.56%
10 YEAR CAGR